Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new system revision entry v3.3.2 was added to the history, replacing the earlier v3.3.1 entry. This is a release-note level update and does not affect study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:51:42.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 was added to the record history, and the previous revision v3.2.0 was removed from the list.
    Difference
    0.1%
    Check dated 2025-11-24T13:27:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Deleted the temporary government funding notice about updates and inquiries during appropriation lapses, which previously warned that the site may be out of date and inquiries delayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:28:57.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    A new version entry dated 2025-04-29 was added to the Study Record Versions table. No other page content appears to have changed.
    Difference
    0.1%
    Check dated 2025-11-03T01:10:49.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-05T09:50:07.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-28T03:10:00.000Z thumbnail image

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.